Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Knownwell vs Primary Clinic (Direct GLP)

Knownwell
Graded #172

Higher grade

vs+1.4000000000000057
Primary Clinic (Direct GLP)
Graded #219

Lower grade

The verdict

Knownwell takes it — 66.9/100 to 65.5/100, but only just.

Knownwell grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Knownwell is a weight-inclusive metabolic and primary care company co-founded by obesity-medicine specialist Dr. Primary Clinic (Direct GLP) is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePrimary Clinic (Direct GLP) +27
38
65
Dose & formulationKnownwell +22
76
54
Clinical oversightKnownwell +15
90
75
Labs & monitoringPrimary Clinic (Direct GLP) +13
63
76
FulfillmentKnownwell +13
86
73
Contract termsKnownwell +14
55
41
Knownwell · left barPrimary Clinic (Direct GLP) · right bar

The numbers

MetricKnownwellPrimary Clinic (Direct GLP)
WeighScore66.9/10065.5/100
GradeCC
Scorecard rank#172#219
SemaglutideNot disclosed$85/mo (0.25-0.75 mg band, membership required, compounded)
Tirzepatide$349/mo (brand Zepbound)$133/mo (1.25-2.5 mg band, membership required, compounded)
CoverageAll 50 states10 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Knownwell

Graded #172 · C

Strengths

  • Co-founded by obesity-medicine specialist Dr. Angela Fitch
  • Branded FDA-approved GLP-1s (Wegovy, Zepbound, Ozempic, Saxenda)
  • Official LillyDirect provider and Novo Wegovy-pill telehealth partner
  • Accepts insurance, copays as low as $25 for covered patients
  • Weight-inclusive care with dietitians and health coaches

Where it loses points

  • Specific self-pay monthly medication prices not transparently posted
  • In-person clinics limited to four metro areas
  • Branded-only focus can mean higher cost than compounded routes

Strengths

  • Direct Primary Care model integrates GLP-1 with continuous primary care — unlike most direct-to-consumer platforms
  • GLP-1 at wholesale cost with no markup — semaglutide from $65/mo, tirzepatide from $110/mo (members only)
  • Unlimited primary care visits, direct text access, and same-day care bundled in the $89/mo membership
  • Routine labs and thousands of medications included in membership — no surprise bills
  • Per-dose pricing shown publicly for all 8 dose tiers of both semaglutide and tirzepatide

Where it loses points

  • The medication price is on top of an $89/mo direct-primary-care membership, which the FAQ states does not include the drug — all-in is about $174/mo for semaglutide and $222/mo for tirzepatide
  • Prices are published as dose BANDS rather than per dose, and the cheapest tirzepatide band starts at 1.25 mg, below the 2.5 mg labelled starting dose
  • The pricing is rendered entirely in JavaScript, so nothing on the page is readable without running the site's bundle
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard